Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP471493.RA3cjdT2WJdoW87vjqkpiGbFQxC1F4w23DjFHW1TR70N8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP471493.RA3cjdT2WJdoW87vjqkpiGbFQxC1F4w23DjFHW1TR70N8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP471493.RA3cjdT2WJdoW87vjqkpiGbFQxC1F4w23DjFHW1TR70N8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP471493.RA3cjdT2WJdoW87vjqkpiGbFQxC1F4w23DjFHW1TR70N8130_provenance.
- NP471493.RA3cjdT2WJdoW87vjqkpiGbFQxC1F4w23DjFHW1TR70N8130_assertion description "[Brain imaging studies using positron emission tomography and single photon emission computed tomography have shown that reduction in brain 5-hydroxytryptamine type 2 (5-HT(2)) receptors may be associated with prevention of or relief from depressive symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP471493.RA3cjdT2WJdoW87vjqkpiGbFQxC1F4w23DjFHW1TR70N8130_provenance.
- NP471493.RA3cjdT2WJdoW87vjqkpiGbFQxC1F4w23DjFHW1TR70N8130_assertion evidence source_evidence_literature NP471493.RA3cjdT2WJdoW87vjqkpiGbFQxC1F4w23DjFHW1TR70N8130_provenance.
- NP471493.RA3cjdT2WJdoW87vjqkpiGbFQxC1F4w23DjFHW1TR70N8130_assertion SIO_000772 15948763 NP471493.RA3cjdT2WJdoW87vjqkpiGbFQxC1F4w23DjFHW1TR70N8130_provenance.
- NP471493.RA3cjdT2WJdoW87vjqkpiGbFQxC1F4w23DjFHW1TR70N8130_assertion wasDerivedFrom befree-20150227 NP471493.RA3cjdT2WJdoW87vjqkpiGbFQxC1F4w23DjFHW1TR70N8130_provenance.
- NP471493.RA3cjdT2WJdoW87vjqkpiGbFQxC1F4w23DjFHW1TR70N8130_assertion wasGeneratedBy ECO_0000203 NP471493.RA3cjdT2WJdoW87vjqkpiGbFQxC1F4w23DjFHW1TR70N8130_provenance.
- befree-20150227 importedOn "2015-02-27" NP471493.RA3cjdT2WJdoW87vjqkpiGbFQxC1F4w23DjFHW1TR70N8130_provenance.